| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfae81468523c4a7e635145a1bfe2359 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2058306-A1 |
| titleOfInvention |
Heteroaryl-substituted 2-pyridinyl-methylamine derivatives |
| abstract |
The present disclosure relates to compounds having the general formula In nwherein Q represents a five membered heteroaryl group. The compounds are selective 5-HT1a modulators and are useful for treating several diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109563073-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562853-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017220799-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109563073-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3260452-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019194132-A1 |
| priorityDate |
2007-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |